Repository logo

  • Help
  • Log In(current)
    1. Home
    2. NT Health Research
    3. Research and Conference Publications
    4. The Australian-New Zealand spontaneous coronary artery dissection cohort study: predictors of major adverse cardiovascular events and recurrence.
    Details
    Title

    The Australian-New Zealand spontaneous coronary artery dissection cohort study: predictors of major adverse cardiovascular events and recurrence.

    Link to article in PubMed
    https://pubmed.ncbi.nlm.nih.gov/40049585/?otool=iaurydwlib
    Author(s)
    Dang, Quan M
    Psaltis, Peter J
    Burgess, Sonya
    Chandrasekhar, Jaya
    Mukherjee, Swati
    Kritharides, Leonard
    Jepson, Nigel
    Fairley, Sarah
    Ihdayhid, Abdul
    Layland, Jamie
    Szirt, Richard
    El-Jack, Seif
    Puri, Aniket
    Davis, Esther
    Shiekh, Imran
    Arnold, Ruth
    Watts, Monique
    Marathe, Jessica A
    Bhagwandeen, Rohan
    Wing-Lun, Edwina
    Bhindi, Ravinay
    Ford, Tom
    Lo, Sidney
    Marschner, Simone
    Zaman, Sarah
    Abstract
    Spontaneous coronary artery dissection (SCAD) is an increasingly recognized cause of acute coronary syndrome (ACS). Recent data suggest a harmful association of dual antiplatelet therapy compared with single antiplatelet therapy following SCAD. This study investigated independent predictors of major adverse cardiovascular events (MACEs) and recurrence in patients with SCAD.This multicentre cohort study involving 23 Australian and New Zealand sites included patients aged ≥18 years with an ACS due to SCAD confirmed on core laboratory adjudication. Multivariable Cox proportional hazard models analysed predictors for the primary MACE outcome.Among 586 patients, 505 (150 prospective, 355 retrospective) with SCAD confirmed by core laboratory adjudication, mean age was 52.2 ± 10.6 years, 88.6% were female, and 74.5% were Caucasian. At long-term follow-up (median 21 months), MACE and SCAD recurrence occurred in 8.6% and 3.6% of patients, respectively. Oral anticoagulation on discharge [adjusted hazard ratio (aHR) 3.8, 95% confidence interval (CI) 1.6-9.3, P = .003], ticagrelor combined with aspirin (aHR 1.8, 95% CI 1.04-3.2, P = .037), fibromuscular dysplasia (aHR 2.2, 95% CI 1.05-4.5, P = .037), and history of stroke (aHR 3.8, 95% CI 1.2-12.2, P = .03) were independently associated with higher MACE. Fibromuscular dysplasia (aHR 3.9, 95% CI 1.5-26.5, P = .01), ticagrelor combined with aspirin (aHR 2.6, 95% CI 2.1-5.3, P = .01), and history of stroke (aHR 6.2, 95% CI 1.8-9.5, P = .01) were also associated with higher SCAD recurrence.The findings support the hypothesis that SCAD is primarily caused by intramural bleeding, with a harmful association of more potent antiplatelet therapy and anticoagulation with adverse cardiovascular outcomes.
    Publication information
    Eur Heart J. 2025 Jun 2;46(21):2012-2023. doi: 10.1093/eurheartj/ehaf097. PMID: 40049585; PMCID: PMC12127729. Online ahead of print 7 March 2025.
    Date Issued
    2025-03-07
    Type
    Journal Article
    Subjects
    Acute coronary syndrome
    Anticoagulation
    Fibromuscular dysplasia
    Major adverse cardiovascular event
    Myocardial infarction
    Recurrence
    Spontaneous coronary artery dissection
    Ticagrelor
    Journal Title
    European heart journal
    Permanent link to this record
    https://hdl.handle.net/10137/14175
    ISSN
    1522-9645
    Owning collection
    Research and Conference Publications

    NT Health Library Services acknowledges the Traditional Custodians of Country throughout the Northern Territory and recognises their continuing cultural and spiritual connections to the lands, waters, and communities. We pay our respects to elders past, present and emerging, and extend that respect to all Aboriginal and Torres Strait Islander people across the Northern Territory and beyond, many of whom are represented in our collections.

    © 2025 Northern Territory Government of Australia